These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37400884)

  • 1. The impact of enhanced screening for carbapenemase-producing Enterobacterales in an acute care hospital in South Korea.
    Park SH; Yi Y; Suh W; Ji SK; Han E; Shin S
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):62. PubMed ID: 37400884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of carbapenemase producing Enterobacterales colonization and risk factor of clinical infection.
    Lee KH; Kim D; Hong JS; Park SY; Cho NH; Kim MN; Lee YJ; Wi Y; Lee EH; Han SH; Jeong SH; Song YG
    J Infect Public Health; 2023 Nov; 16(11):1860-1869. PubMed ID: 37837922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care.
    Otter JA; Mookerjee S; Davies F; Bolt F; Dyakova E; Shersing Y; Boonyasiri A; Weiße AY; Gilchrist M; Galletly TJ; Brannigan ET; Holmes AH
    J Antimicrob Chemother; 2020 Sep; 75(9):2670-2676. PubMed ID: 32479615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review.
    Bar Ilan M; Kjerulf A
    J Hosp Infect; 2023 Dec; 142():74-87. PubMed ID: 37802236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
    Huang YT; Kuo YW; Lee NY; Tien N; Liao CH; Teng LJ; Ko WC; Hsueh PR;
    Microbiol Spectr; 2022 Feb; 10(1):e0172821. PubMed ID: 35019772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting.
    Pople D; Kypraios T; Donker T; Stoesser N; Seale AC; George R; Dodgson A; Freeman R; Hope R; Walker AS; Hopkins S; Robotham J
    BMC Med; 2023 Dec; 21(1):492. PubMed ID: 38087343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the Xpert
    Hoyos-Mallecot Y; Ouzani S; Dortet L; Fortineau N; Naas T
    Int J Antimicrob Agents; 2017 Jun; 49(6):774-777. PubMed ID: 28411078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.
    Kardaś-Słoma L; Fournier S; Dupont JC; Rochaix L; Birgand G; Zahar JR; Lescure FX; Kernéis S; Durand-Zaleski I; Lucet JC
    Antimicrob Resist Infect Control; 2022 Sep; 11(1):117. PubMed ID: 36117231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Clinical Outcomes of Patients With Positive Xpert Carba-R Tests for Carbapenemase-Producing Enterobacterales According to Culture Positivity.
    Seo H; Lee JY; Ryu SH; Kwak SH; Kim EO; Bae S; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Sung H; Kim MN; Kim YS; Jung J
    Open Forum Infect Dis; 2022 Jan; 9(1):ofab594. PubMed ID: 35036462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of an outbreak of carbapenemase producing-Enterobacteriaceae in a surgical intensive care unit.
    Atchade E; Goldstein V; Viane S; Van Gysel D; Lolom I; Lortat-Jacob B; Tran-Dinh A; Ben Rehouma M; Lucet JC; Montravers P
    Anaesth Crit Care Pain Med; 2022 Aug; 41(4):101093. PubMed ID: 35504523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Household Transmission of Carbapenemase-producing Enterobacterales in Ontario, Canada.
    Jamal AJ; Faheem A; Farooqi L; Zhong XZ; Armstrong I; Boyd DA; Borgundvaag E; Coleman BL; Green K; Jayasinghe K; Johnstone J; Katz K; Kohler P; Li AX; Mataseje L; Melano R; Muller MP; Mulvey MR; Nayani S; Patel SN; Paterson A; Poutanen S; Rebbapragada A; Richardson D; Sarabia A; Shafinaz S; Simor AE; Willey BM; Wisely L; McGeer AJ
    Clin Infect Dis; 2021 Dec; 73(11):e4607-e4615. PubMed ID: 32869855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
    Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
    J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term contamination of sink drains by carbapenemase-producing Enterobacterales in three intensive care units: characteristics and transmission to patients.
    Lemarié C; Legeay C; Mahieu R; Moal F; Ramont C; Kouatchet A; Eveillard M
    J Hosp Infect; 2021 Jun; 112():16-20. PubMed ID: 33636255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenemase-producing enterobacterales colonisation status does not lead to more frequent admissions: a linked patient study.
    Lydeamore MJ; Donker T; Wu D; Gorrie C; Turner A; Easton M; Hennessy D; Geard N; Howden BP; Cooper BS; Wilson A; Peleg AY; Stewardson AJ
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):82. PubMed ID: 39075552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area.
    Papafotiou C; Roussos S; Sypsa V; Bampali S; Spyridopoulou K; Karapanou A; Moussouli A; Samarkos M; Daikos GL; Psichogiou M
    J Antimicrob Chemother; 2022 Nov; 77(12):3331-3339. PubMed ID: 36203392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study.
    Hoellinger B; Deboscker S; Danion F; Lavigne T; Severac F; Ruch Y; Ursenbach A; Lefebvre N; Boyer P; Hansmann Y
    Microbiol Spectr; 2022 Dec; 10(6):e0186822. PubMed ID: 36321906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study.
    Henoun Loukili N; Loquet A; Perrin A; Gaillot O; Bruandet A; Sendid B; Zahar JR; Nseir S
    J Hosp Infect; 2023 May; 135():4-10. PubMed ID: 36871872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of the Xpert Carba-R™ assay directly from rectal swabs for active surveillance of carbapenemase-producing organisms in the largest Brazilian University Hospital.
    Cury AP; Almeida Junior JN; Costa SF; Salomão MC; Boszczowski Í; Duarte AJS; Rossi F
    J Microbiol Methods; 2020 Apr; 171():105884. PubMed ID: 32142746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.